GHENT, BELGIUM--(Marketwire - July 26, 2011) -
GHENT, Belgium, 26 July 2011 - Ablynx [Euronext Brussels: ABLX] today
that it has been granted a Certificate of Good Laboratory Practise (GLP)
the Belgian Scientific Institute of Public Health (IPH) for its new GLP
its headquarters in Ghent, Belgium, after having been inspected in May
Having received this GLP certificate, Ablynx's GLP unit will be
seamlessly carry out pre-clinical analytical testing and
studies in-house, to the required regulatory standard.
Dr Edwin Moses, CEO and Chairman of Ablynx, commented: "Being awarded
certificate from the Belgian authorities confirms our commitment to
perform at a high standard in this stringent regulatory environment. This
important milestone for Ablynx as we continue to grow towards a product-
company. With this certificate, we no longer solely rely on third
carry out the pre-clinical GLP testing for our programmes. This enables
retain more control on quality, timing and associated costs."
About Good Laboratory Practise (GLP)
Good Laboratory Practise specifically refers to a quality system of
controls for research laboratories and organisations to ensure the
consistency, reliability, reproducibility, quality, and integrity of
(including pharmaceuticals) safety and efficacy tests.
Complete version of the press release:
This announcement is distributed by Thomson Reuters on behalf of
Thomson Reuters clients. The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and
other applicable laws; and
(ii) they are solely responsible for the content, accuracy and
originality of the information contained therein.
Source: Ablynx via Thomson Reuters ONE